[1] KAWAR B, ELIAM T, JACKSON C, et al. Pulmonary hypertension in renal disease: potential mechanisms and implications[J]. Am J Nephrol, 2013, 37(3): 281. doi: 10.1159/000348804
[2] YIGLA M, FRUCHTER 0, AHARONSON D, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients[J]. Kidney Int, 2009, 7(5): 969.
[3] 周蓓蓓. 超声心动图在评价尿毒症患者心脏结构及功能改变中的应用[J]. 蚌埠医学院学报, 2015, 40(7): 956
[4] AGARWAL R. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients[J]. Nephrol Dial Transplant, 2015, 27(10): 3908.
[5] YIGLA M, NAKHOUL F, SABAG A, et al. Pulmonary hypertension in patients with end stage renal disease[J]. Chest, 2003, 123(5): 1577. doi: 10.1378/chest.123.5.1577
[6] REQUE J, QUIROGA B, RUIZ C, et al. Pulmonary hypertension is an independent predictor of cardiovascular events and mortality in haemodialysis patients[J]. Nephrology(Carlton), 2016, 21(4): 321.
[7] LI Z, LIU S, SLIANG X, et al. Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients[J]. Int Urol Nephrol, 2016, 46(1): 141.
[8] PEACOCK AJ, MURPHY NF, MCMURRAY JJ, et al. An epidemigical study of pulmonary arterial hypertension[J]. Eur Respir J, 2007, 30(1): 104. doi: 10.1183/09031936.00092306
[9] 贺艳军, 王玉玲, 李妙根, 等. 维持性血液透析患者发生肺动脉高压的风险因素分析[J]. 中华临床医师杂志, 2014, 8(12): 2264.
[10] 潘敏, 金领微, 李占园, 等. 维持性血液透析患者发生肺动脉高压的危险因素分析[J]. 中国中西医结合肾病杂志, 2013, 14(6): 520. doi: 10.3969/j.issn.1009-587X.2013.06.016
[11] 米爱红. 血液透析患者并发肺动脉高压的临床效果观察[J]. 中国医药指南, 2014, 6(13): 121.
[12] 王娟. 血液透析对尿毒症患者肺动脉压产生的影响观察[J]. 世界中医药, 2015, 10(A01): 431.
[13] NITTA K, AKIBA T, UCHIDA K, et al. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis[J]. Am J Kidney Dis, 2003, 42(2): 303. doi: 10.1016/S0272-6386(03)00655-3
[14] TAMOSIUNIENE R, TIAN W, DHILLON G, et al. Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension[J]. Circ Res, 2017, 109(8): 867.
[15] SWAMJNATHAN S, SHAH SV. Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease[J]. Kidney Int, 2011, 80(5): 453. doi: 10.1038/ki.2011.178
[16] 陈荣毅, 项方方, 胡家昌, 等. 维持性血液透析患者肺动脉高压与外周血CD8细胞比率降低相关[J]. 中华肾脏病杂志, 2017, 33(5): 342. doi: 10.3760/cma.j.issn.1001-7097.2017.05.004
[17] 张颖, 夏思良. 超声心动图评估血液透析患者并发肺动脉高压的研究[J]. 中华全科医学, 2012, 10(4): 630.
[18] 潘敏, 金领微, 李占园, 等. 维持性血液透析患者发生肺动脉高压的危险因素分析[J]. 中国中西医结合肾病杂志, 2013, 14(6): 520. doi: 10.3969/j.issn.1009-587X.2013.06.016
[19] 杨文艳, 王建爽, 王艳辉, 等. 老年维持性血液透析患者肺动脉高压与超声心动图参数的相关性[J]. 实用老年医学, 2016, 11(30): 899.
[20] 王艺萍, 赵娜, 刘煜, 等. 尿毒症难治性继发性甲状旁腺功能亢进症患者肺动脉压变化及其相关因素分析[J]. 兰州大学学报(医学版), 2014, 3(40): 17.